Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin Receptor Type 4 (SSTR4) is a G protein-coupled receptor that mediates the inhibitory effects of somatostatin on hormone secretion, modulates neuronal activity, and plays roles in metabolism, growth regulation, pain modulation, inflammation control, and potentially tumor suppression. It is a promising therapeutic target for chronic pain, inflammatory diseases, and certain cancers due to its antinociceptive and anti-inflammatory effects without significant impact on endocrine functions.
Activation by somatostatin leads to coupling with G proteins that inhibit adenylyl cyclase activity, resulting in decreased cyclic AMP (cAMP) levels within cells. Also functionally linked to activation of arachidonate release and mitogen‐activated protein kinase (MAPK) cascade pathways.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin Receptor Type 4 (SSTR4).